Robert J. Porte

Graft loss after pediatric liver transplantation.

Aprotinin and thromboembolism in liver transplantation: is there really a causal effect?

Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.

Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis.

Antifibrinolytics in liver transplantation: they are effective, but what about the risk-benefit ratio?

Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.

Orthotopic liver transplantation for portosystemic encephalopathy in an adult with congenital absence of the portal vein.

Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases.

Blood conservation in liver transplantation: The role of aprotinin.

Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults.

Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation.

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.

Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation.

Sequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation.

The role of recombinant factor VIIa in liver transplantation.

Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.

Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.

Minimizing blood loss in liver transplantation: progress through research and evolution of techniques.

Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.

The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.

Analysis of differences in outcome of two European liver transplant centers.

Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice.

Anastomotic biliary strictures after liver transplantation: causes and consequences.

Surgical injuries of postmortem donor livers: incidence and impact on outcome after adult liver transplantation.

Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.

Biliary complications after liver transplantation: a review.

Antifibrinolytics in liver transplantation.

Should donors and recipients be matched in liver transplantation?

End-to-side caval anastomosis in adult piggyback liver transplantation.

Outcome and pattern of recurrence after curative resection for hepatocellular carcinoma in patients with a normal liver compared to patients with a diseased liver.

The sequence of revascularization in liver transplantation: it does make a difference.

Spatiotemporal expression of heme oxygenase-1 detected by in vivo bioluminescence after hepatic ischemia in HO-1/Luc mice.

Fluordeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin.

Causes and consequences of ischemic-type biliary lesions after liver transplantation.

How to make steatotic livers suitable for transplantation.

Antiplatelet medication after liver transplantation: does it affect outcome?

Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation.

Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression.

Impact of blood loss on outcome after liver resection.

Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.

The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation.

A benefit-risk review of systemic haemostatic agents: part 1: in major surgery.

The outcome of primary liver transplantation from deceased donors in children with body weight < or =10 kg.

A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.

Chronic hepatitis E virus infection in liver transplant recipients.

Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression.

Interlaboratory variability in assessment of the model of end-stage liver disease score.

The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation.

Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.

Platelets in liver transplantation: friend or foe?

The survival paradox of elderly patients after major liver resections.

The two tales of coagulation in liver transplantation.

Aprotinin and lysine analogues in high-risk cardiac surgery.

Hepatic artery thrombosis after liver transplantation: more than just a surgical complication?

Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures.

Report of the Paris consensus meeting on expanded criteria donors in liver transplantation.

The platelet and platelet function testing in liver disease.

Bleeding in liver surgery: prevention and treatment.

Who should get a liver graft?

Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury.

Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver.

Smoking behavior in liver transplant recipients.

Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.

Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver.

Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts.

Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients.

Inflammation mediated down-regulation of hepatobiliary transporters contributes to intrahepatic cholestasis and liver damage in murine biliary atresia.

Is Roux-en-Y choledochojejunostomy an independent risk factor for nonanastomotic biliary strictures after liver transplantation?

No evidence for systemic platelet activation during or after orthotopic liver transplantation.

Transmission of idiopathic thrombocytopenic purpura during orthotopic liver transplantation.

Topical haemostatic agents in liver surgery: do we need them?

The clinical relevance of the anhepatic phase during liver transplantation.

Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection.

Prevalence of hepatitis E virus infection in liver transplant recipients.

How to minimize blood loss during liver surgery in patients with cirrhosis.

Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.

Regulation of VDR expression in rat and human intestine and liver--consequences for CYP3A expression.

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.

Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis.

Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b.

Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences.

The role of platelets in liver inflammation and regeneration.

Hemostasis and thrombosis in patients with liver disease: the ups and downs.

Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation.

Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation.

Activation and regulation of hemostasis in acute liver failure and acute pancreatitis.

The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices.

The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver.

The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.

Honoring the contract with our patients: outcome after repeated re-transplantation of the liver.

Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.

Surgical treatment of renal cell cancer liver metastases: a population-based study.

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.

Protection of bile ducts in liver transplantation: looking beyond ischemia.

Towards a rational use of low-molecular-weight heparin in patients with cirrhosis.

Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation.

Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver.

A prospective analysis of the natural course of donor chimerism including the natural killer cell fraction after liver transplantation.

Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation.

Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities.

Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study.

Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.

Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment.

Pitfalls in assessing platelet activation status in patients with liver disease.

Rapamycin induces heme oxygenase-1 in liver but inhibits bile flow recovery after ischemia.

Platelet function in patients with cirrhosis.

Role of fibrin sealants in liver surgery.

Prohemostatic interventions in liver surgery.

Liver transplantation for unresectable hepatocellular carcinoma in normal livers.

Course of life into adulthood of patients with biliary atresia: the achievement of developmental milestones in a nationwide cohort.

Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial.

Fibrinolytic proteins in human bile accelerate lysis of plasma clots and induce breakdown of fibrin sealants.

Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review.

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

The impact of hepatic steatosis on liver regeneration after partial hepatectomy.

Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience.

The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study.

The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts?

An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.

Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.

Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.

MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.

Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.

Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.

Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation.

Reply to letter: "Fibrin sealants do not prevent resection surface-related complications after liver resection".

Influence of preoperative chemotherapy on CT volumetric liver regeneration following right hemihepatectomy.

Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcome from a single center.

Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy.

Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.

Hypothermic oxygenated machine perfusion prevents arteriolonecrosis of the peribiliary plexus in pig livers donated after circulatory death.

Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures.

Reply to letter: Fibrin sealants do not prevent resection surface-related complications after liver resection.

Hemostasis in liver disease: implications of new concepts for perioperative management.

Biliary complications after orthotopic liver transplantation.

The quest for Luschka's duct: an eponym leading a life of its own?

Shared decision making in transplantation: how patients see their role in the decision process of accepting a donor liver.

Management of coagulation abnormalities in liver disease.

Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions.

Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival.

Opinions of dutch liver transplant recipients on anonymity of organ donation and direct contact with the donors family.

Opportunities for scientific expansion of the deceased donor pool.

Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.

Reply.

Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.

No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.

The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.

Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?

Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.

Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.

Evidence against a role of serotonin in liver regeneration in humans.

Diffuse reflectance spectroscopy: toward real-time quantification of steatosis in liver.

Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation.

Fibrocaps for surgical hemostasis: two randomized, controlled phase II trials.

Development of a hypercoagulable status in patients undergoing off-pump lung transplantation despite prolonged conventional coagulation tests.

Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection.

High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.

Achievement of developmental milestones in young adults after liver transplantation in childhood.

Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.

Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: Rationale, current evidence and future directions.

Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.

Risk factors associated with outcome in liver retransplantation: multicentric study.

Intra-operative continuous renal replacement therapy during combined liver-kidney transplantation in two patients with primary hyperoxaluria type 1.

Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study.